Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11673930 IL10 agonists and methods of use thereof
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
May 11, 2021
0
Date of Patent
June 13, 2023
0
Patent Applicant
Regeneron Pharmaceuticals
0
Patent Application Number
17317475
0
Patent Citations
US Patent 10195274 Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10
0
US Patent 10357545 Methods of using interleukin-10 for treating solid tumors
0
US Patent 10335459 Compositions for modulating IL-10 immunostimulatory and anti-inflammatory properties
0
US Patent 7261882 Methods for treating neuropathic pain by administering IL-10 polypeptides
0
US Patent 7939056 Interleukin-10 compositions for the treatment of adenocarcinomas
0
US Patent 10040843 Interleukin-10 fusion proteins and uses thereof
0
US Patent 10143726 Methods of using interleukin-10 for treating diseases and disorders
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11673930
0
Patent Primary Examiner
Jeffrey E. Russel
0
CPC Code
A61K 47/6889
0
A61P 35/00
0
A61K 38/2066
0
C07K 2319/30
0
C07K 14/5428
0
A61K 47/68
0
Find more entities like US Patent 11673930 IL10 agonists and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE